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Background: We compared the clinical characteristics and outcomes between the new definition of 
sepsis-3 septic shock and the definition previously used from 1991 until recently.
Methods: We conducted an observational study using a prospective, multi-center registry of septic shock 
from October 2015 to February 2017. Registry data were collected by 10 emergency departments (EDs) 
in tertiary hospitals that are members of the Korean Shock Society. Data on septic shock patients who met 
the previous septic shock definition were collected. The patients were divided into a sepsis-3 defined septic 
shock group, made up of those who met the new criteria for refractory hypotension with hyperlactatemia, 
and a group of those who met only the 1991 definition for septic shock. The primary outcome was 90-day 
mortality, and secondary outcomes were 28-day mortality and in-hospital mortality. 
Results: Of all 1,028 included patients, 574 (55.8%) met the septic shock criteria for sepsis-3, leaving 
454 patients who met only the previous definition. Those who met the sepsis-3 criteria demonstrated 
higher comorbidity than those who met the previous definition (83.1% vs. 75.3%, P<0.01), but there was 
no difference in infection focus. The sequential organ failure assessment (SOFA) (initial/maximal), the 
acute physiology, and the chronic health evaluation II scores were significantly higher in for those who 
met the sepsis-3 criteria [6.5±3.1 vs. 5.0±2.9, 9.3±3.8 vs. 6.6±3.4, and 20.0 (15.0–26.0) vs. 15.0 (10.0–20.3), 
respectively; P<0.01]. The 90-day mortality was significantly higher in the sepsis-3 group (32.1% vs. 23.3%; 
P<0.01). In-hospital and 28-day mortality were also higher in the sepsis-3 group (26.8% vs. 17.1% and 
25.1% vs. 16.5%, respectively; P<0.01).
Conclusions: The new definition of septic shock successfully selected patients with greater severities and 
worse outcomes. 
853
846 Ryoo et al. Sepsis-3 vs. 1991 defined septic shock
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2018;10(2):845-853jtd.amegroups.com
Introduction 
The 1991 American College of Chest Physician and Society 
of Critical Care Medicine consensus conference developed 
initial definitions of sepsis to standardize its definition 
and spectrum (1). The participants focused on the host’s 
systemic inflammatory response syndrome (SIRS), and 
sepsis was defined as infection in patients with SIRS (1). 
Organ dysfunction developing in sepsis was termed severe 
sepsis, and septic shock was defined as occurring when 
sepsis-induced hypotension or perfusion abnormality 
persists despite adequate fluid resuscitation (1). Although 
these definitions have regularized communication in both 
the clinical and the research settings, criticisms of the 
definitions have been reported, such as the limitations of 
the SIRS criteria and the overly sensitive sepsis definition 
(2-7). 
The Third International Consensus Definitions Task 
Force recently proposed new criteria of sepsis and septic 
shock (Sepis-3) (8). Sepsis was defined as evidence of 
infection plus life-threatening organ dysfunction, clinically 
characterized by an acute change in the sequential organ 
failure assessment (SOFA) score ≥2. The definition of septic 
shock was altered to a subset of sepsis with underlying 
circulatory and cellular metabolism abnormality (8). Patients 
with septic shock are identified by a clinical construct of 
sepsis with persisting hypotension requiring vasopressors to 
maintain mean arterial pressure (MAP) ≥65 mmHg and to 
have a serum lactate level >2 mmol/L (18 mg/dL) despite 
adequate volume resuscitation. According to these criteria, 
hospital mortality is in excess of 40%. Although the use 
of large databases provides support for the new consensus 
definitions of sepsis and septic shock (9), there remain 
concerns over the information used to generate the updated 
criteria, particularly in the inclusion of serum lactate levels 
in the definition of septic shock.
Our present study compared clinical characteristics, 
severities, and outcomes between septic shock defined 
according to the new sepsis-3 criteria and using the previous 
criteria. 
Methods
Setting and study population
This observational study used a prospective, multi-center 
registry provided by the Korean Shock Society (KoSS septic 
shock registry) with data from October 2015 to February 
2017 to compare the clinical characteristics and outcomes of 
patients with septic shock defined by sepsis-3 and the 1991 
definition. The KoSS is a collaborative research network that 
investigates and works to improve the quality of diagnosis 
and management for sepsis. It was organized in 2013, and 
KoSS investigators began prospectively collecting data from 
septic shock patients at the emergency departments (EDs) 
of 10 teaching hospitals throughout South Korea in October 
2015. The institutional review board of each institution 
approved the study protocol and informed consent was 
obtained before data collection (Asan Medical Center 
Institutional Review Board No. 2015-1283) (10).
Adult (≥18 years old) septic shock patients, defined 
according to the 1991 septic shock definition, which 
included suspected or confirmed infection and evidence of 
refractory hypotension or hypoperfusion, were enrolled in 
the registry (11-13). Refractory hypotension was defined 
as persistent hypotension: systolic blood pressure (SBP) 
<90 mmHg, MAP <70 mmHg, or SBP decrease >40 mmHg 
after adequate intravenous fluid challenge (20–30 mL/kg 
or at least 1 L or more of crystalloid solution administered 
over 30 min) or as the need for vasopressors after fluid 
resuscitation (14,15). Hypoperfusion was defined as a serum 
lactate concentration of 4 mmol/L or greater (16). Patients 
who signed a “do not attempt resuscitation” order, did 
not meet the inclusion criteria within 6 h after ED arrival, 
were transferred from other hospitals without meeting 
the inclusion criteria upon ED arrival, or were directly 
transferred from ED to other hospitals, were not enrolled 
in in the KoSS septic shock registry. 
The case report form, standard definitions of 200 
variables, including clinical characteristics, therapeutic 
interventions, and outcomes of patients with septic 
shock and an investigator manual were developed based 
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on a literature review and the consensus of the study 
investigators. Data was collected via a standardized registry 
form and was entered into a web-based electronic database 
registry. Outliers or incorrect values were primarily filtered 
by this data-entry system. Each site’s principal investigator 
had a designated local research coordinator, who was 
responsible for ensuring the accuracy of data entry and 
verifying records. In each ED, a quality management 
committee (QMC), which consisted of emergency 
physicians, local research coordinators, and investigators 
were organized to monitor and regularly review data quality. 
The QMCs gave feedback to the research coordinators and 
investigators of the results of their QM processes through 
the query function in the system or directly by phone to 
clarify data.
Data collection
Demographic and clinical data, including age, sex, previous 
medical history, initial vital signs, severity, laboratory values 
on admission, and interventions were retrieved from the 
septic shock registry. Among septic shock patients in the 
KoSS registry, patients who had refractory hypotension 
with hyperlactatemia (≥2 mmol/L) were defined as having 
sepsis-3 septic shock (8). The patients were divided into a 
sepsis-3-defined septic-shock group and a group that only 
met the previous 1991 definition of septic shock.
The patient’s severity was assessed using a disease 
severity score. The maximum SOFA and acute physiology 
and chronic health evaluation (APACHE) II scores were 
evaluated using the worst parameters within 24 h of ED 
arrival. The outcome variables included in-hospital, 28-, 
and 90-day mortalities and length of hospital stay. 
Statistical analysis
Continuous variables are expressed as means ± standard 
deviations (SD) or medians with interquartile ranges 
(IQR) if the assumption of a normal distribution was 
violated. Categorical variables were expressed as numbers 
and percentages. Baseline characteristics and laboratory 
examinations were analyzed for the sepsis-3 defined septic 
shock group and the group that only met previous 1991 
defined septic shock. The Student’s t-test was used to 
compare the means of normally distributed continuous 
variables, whereas the Mann-Whitney U-test was used 
to compare non-continuous variables. The chi-square or 
Fisher’s exact test was used to compare categorical variables. 
All tests in this study were two-sided, and a p values 
<0.01 were considered statistically significant. All statistical 
analyses were performed using SPSS for Windows version 
20.0 (SPSS Inc., Chicago, IL, USA).
Results
Of the 1,046 eligible patients in KoSS septic shock registry, 
we excluded 18 patients who had missing data. The 
included 1,028 patients were divided into 574 (55.8%) who 
met the sepsis-3 criteria for septic shock, namely, refractory 
hypotension with hyperlactatemia, leaving 454 patients who 
met only the 1991 definition of septic shock, of whom 206 
(20.0%) had hyperlactatemia without hypotension and 248 
(24.2%) had refractory hypotension with normal lactate 
(Figure 1). 
The sepsis-3 criteria group demonstrated higher 
comorbidity with hypertension (46.5% vs. 37.9%; P=0.005), 
diabetes (35.2% vs. 21.6%; P<0.001), and chronic liver 
disease (14.6% vs. 7.9%; P=0.001) than the 1991 septic 
shock group. The vital signs of the sepsis-3 shock group 
were more severe than 1991 septic shock group. They 
were more hypotensive in both the systolic (87.3±21.3 vs. 
90.9±23.5; P=0.011) and diastolic (52.7±15.1 vs. 55.5±15.9; 
P=0.004) measures, had tachycardia (109.2±24.0 vs. 
101.5±23.1; P<0.001), and experienced mental change 
(26.5% vs. 21.1%; P=0.047) (Table 1).
The most common foci of infection were the lung 
(32.1%) and urinary tract (24.3%), and the hepatobiliary–
pancreatic area (20.2%) and gastrointestinal tract (17.1%) 
followed. However, the distribution was not significant 
for either group. In both groups, empirical antibiotics 
were administrated 70 minutes from recognition of shock; 
however, the IQR of the sepsis-3 shock group was more 
delayed than was that of the 1991 septic shock group 
(P=0.046) (Table 1).
All severity scores were also significantly higher in the 
sepsis-3 shock group than in the 1991 septic shock group 
(Table 2). In-hospital mortality, 28- and 90-day mortality 
were higher in the sepsis-3 shock group as well [23.3% vs. 
15.0%, OR: 1.73 (95% CI: 1.25–2.39); 25.1% vs. 16.5%, 
OR: 1.67 (95% CI: 1.22–2.28); and 32.1% vs. 23.3%, OR: 
1.40 (95% CI: 1.04–1.88), respectively]. Within the 1991 
defined septic shock group, Hyperlactatemia without 
hypotension had higher in-hospital, 28-day, and 90-day 
mortality than refractory hypotension with normal lactate 
group [19.9% vs.10.9%, OR: 2.03 (95% CI: 1.20–3.44); 
21.8% vs. 12.1%, OR: 2.18 (95% CI: 1.31–3.63); 29.6% 
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vs. 18.1% OR: 1.96 (95% CI: 1.23–3.12), respectively] 
(Figure 2). However, the length of stay did not differ 
significantly (Table 2).
Discussion
In this study, we compared clinical manifestations between 
sepsis-3 defined septic shock patients within 1991 defined 
septic shock registry and leaving septic shock patients who 
met only 1991 definition in the registry. We found in our 
current investigation that 55.8% of patients with septic 
shock as defined in 1991 met the new sepsis-3 defined septic 
shock criteria. Their 90-day mortality was 32.1%, which was 
significantly higher than that of the group only meeting the 
1991 definition of septic shock (23.3%). It means refractory 
hypotension with hyperlactatemia was more severe than 
either refractory hypotension or hyperlactatemia alone. 
Unlike the previous 1991 criteria septic shock, sepsis-3 
shock emphasizes cellular metabolic abnormalities (8). 
This is because the pathophysiologic aspect of shock is 
circulatory failure that results in inadequate cellular oxygen 
utilization (17). In tissue with hypoxia, whether global or 
localized, lactate is overproduced and underutilized as a 
result of impaired mitochondrial oxidation (18). For this 
reason, hyperlactatemia is an essential part of the septic-3 
definition of shock (8). Anaerobic metabolism, as well as 
β2 receptor stimulation by endogenous and exogenous 
catecholamines, overproduces serum lactate (19-21). 
Therefore, in septic shock, the degree of hyperlactatemia 
reflects the severity of disease, and the guidelines for 
surviving sepsis recommend serum lactate measurement 
within 3 h of recognition of shock (16,22,23).
A previous study reported that risk-adjusted hospital 
mortality was significantly higher (P<0.001 compared to the 
reference group) in patients with fluid-resistant hypotension 
requiring vasopressors and hyperlactatemia (42.3% and 
49.7% at thresholds for serum lactate level of >2 or 
> 4  m m o l / L ,  r e s p e c t i v e l y )  c o m p a r e d  t o  e i t h e r 
hyperlactatemia alone (25.7% and 29.9% mortality for those 
with serum lactate level of >2 and >4 mmol/L, respectively) 
or with fluid-resistant hypotension requiring vasopressors 
but with a lactate level of 2 mmol/L or less (30.1%) (8). 
These results were reproduced by two unrelated large 
electronic health record datasets [University of Pittsburgh 
Medical Center (12 hospitals; 2010–2012; n=5,984) and 
Kaiser Permanente Northern California (20 hospitals; 
2009–2013; n=54,135)]. The combination of hypotension, 
vasopressor use, and lactate level greater than 2 mmol/L 
identified patients with mortality rates of 54% and 35%, 
higher than mortality in patients with hypotension alone 
(25.2% and 18.8%) or in patients with lactate levels greater 
than 2 mmol/L alone (20.0% and 8.0%) (8). Another study 
compared lactate levels to determine the association of in-
hospital mortality; the researchers showed that hypotension 
with hyperlactatemia of lactate >2 mmol/L had a significant 
higher mortality than hypotension only [OR: 1.16 (95% 
Figure 1 Diagram of included patients. 
Eligible patients in septic shock registry
(n=1,046)
Included patients
(n=1,028)
Sepsis-3 defined septic shock
(n=574, 55.8%)
1991 defined septic shock only
(n=454, 44.2%)
Hyperlactatemia without
hypotension
(n=206, 20.0%)
Refractory hypotension
with normal lactate
(n=248, 24.2%)
Exclusion: missing data (n=18)
849Journal of Thoracic Disease, Vol 10, No 2 February 2018
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2018;10(2):845-853jtd.amegroups.com
Table 1 Baseline and clinical characteristics of the study population 
Characteristics Total (n=1,028) 1991 septic shock (n=454) Sepsis-3 shock (n=574) P value
Age, years 68.6±13.4 68.2±13.5 68.9±13.3 0.394
Male 585 (56.9) 258 (56.8) 327 (57.0) 0.964
Past medical history
Hypertension 439 (42.7) 172 (37.9) 267 (46.5) 0.005
Stroke 142 (13.8) 61 (13.4) 90 (15.7) 0.313
Diabetes 300 (29.2) 98 (21.6) 202 (35.2) <0.001
Coronary artery disease 151 (14.7) 67 (14.8) 75 (13.1) 0.435
Chronic pulmonary disease 82 (8.0) 48 (10.6) 34 (5.9) 0.006
Metastatic cancer 223 (21.7) 109 (24.0) 114 (19.9) 0.109
Chronic renal disease 85 (8.3) 30 (6.6) 55 (9.6) 0.086
Chronic liver disease 120 (11.7) 36 (7.9) 84 (14.6) 0.001
Vital signs at shock recognition
SBP, mmHg 88.9±22.4 90.9±23.5 87.3±21.3 0.011
Diastolic blood pressure, mmHg 53.9±15.5 55.5±15.9 52.7±15.1 0.004
Pulse rate, beats/min 105.8±23.9 101.5±23.1 109.2±24.0 <0.001
Respiratory rate, breaths/min 22.1±5.7 21.7±5.7 22.3±5.6 0.086
Body temperature, ℃ 37.5±1.2 37.5±1.1 37.5±1.2 0.740
Altered mentality 248 (24.1) 96 (21.1) 152 (26.5) 0.047
Infection focus
Lung 330 (32.1) 145 (31.9) 185 (32.2) 0.921
Urinary tract 250 (24.3) 104 (22.9) 146 (25.4) 0.348
Hepatobiliary & pancreas 208 (20.2) 80 (17.6) 128 (22.3) 0.064
Gastrointestinal 176 (17.1) 78 (17.2) 98 (17.1) 0.964
Unknown focus 72 (7.0) 38 (8.4) 34 (5.9) 0.127
Duration of first antibiotics use, minutes 70 [15–138] 70 [0–133] 70 [26–142] 0.046
Steroid use 209 (20.3) 58 (12.8) 151 (26.3) <0.001
Values are expressed as means ± SD, medians [IQRs], or numbers (%). SBP, systolic blood pressure; SD, standard deviation; IQR, 
interquartile ranges.
CI: 1.05–1.27) in lactate 2–3 mmol/L; OR: 1.21 (95% CI: 
1.09–1.35) in lactate 3–4 mmol/L, and OR: 2.10 (95% 
CI: 1.93–2.27) in lactate >4 mmol/L, respectively] (24). 
Moreover the mortality of each group was higher than that 
of only hyperlactatemia, with >4 mmol/L (30.6% in lactate 
2–3 mmol/L, 31.6% in lactate 3–4 mmol/L, and 44.5% 
in lactate >4 mmol/L, with hypotension vs. 29.0% in only 
hyperlactatemia >4 mmol/L) (24). 
Since the revision of the definition of sepsis, there 
have been some studies comparing groups according 
to the two definitions. One study, which performed a 
secondary analysis of a multicenter randomized control 
trial, presented higher in-hospital mortality in their sepsis-3 
shock group than their 1991 septic shock group (28.5% vs. 
14.4%, P<0.001) (25). Another cohort study, collected at a 
single center, reported a similar in-hospital mortality rate 
(sepsis-3 shock, 22.9% vs. previous consensus septic shock, 
21.7%) (26). Sterling et al. included patients who met 1991 
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Table 2 Comparison of the severities and outcomes between 1991 and sepsis-3 defined septic shock
Characteristics 1991 septic shock (n=454) Sepsis-3 shock (n=574) P value
Laboratory findings
White blood cell count, 103/μL 11.1 [6.4–17.9] 10.4 [5.1–17.9] 0.077
Hemoglobin, g/dL 11.1 [9.3–12.7] 11.2 [9.5–12.8] 0.562
Blood urea nitrogen, mg/dL 23.8 [16.3–38.7] 29.8 [21.0–44.4] <0.001
Creatinine, mg/dL 1.2 [0.8–1.8] 1.6 [1.1–2.5] <0.001
Aspartate transaminase, IU/L 35.0 [23.0–71.3] 46.0 [27.0–117.0] <0.001
Alanine transaminase, IU/L 24.0 [13.0–45.3] 30.0 [16.0–73.0] <0.001
Initial lactate, mmol/L 1.8 [1.2–4.3] 4.3 [2.8–6.1] <0.001
Severity score
Initial SOFA score 5.0±2.9 6.5±3.1 <0.001
Maximum SOFA score 6.6±3.4 9.3±3.8 <0.001
APACHE-II score 15.0 [10.0–20.3] 20.0 [15.0–26.0] <0.001
Interventions
Mechanical ventilator 100 (22.0) 201 (35.0) <0.001
Duration of mechanical ventilation, days 5.0 [2.0–12.0] 5.0 [2.0–10.0] 0.596
Renal replacement therapy 35 (7.7) 130 (22.6) <0.001
Mortality
In-hospital mortality 68 (15.0) 134 (23.3) 0.001
28-day mortality 75 (16.5) 144 (25.1) 0.003
90-day mortality 106 (23.3) 184 (32.1) 0.002
Length of stay, days
Hospital stay 12.0 [7.0–20.0] 13.0 [7.0–24.0] 0.088
ICU stay 4.0 [2.0–8.0] 5.0 [3.0–8.0] 0.322
Values are expressed as means ± SDs, medians [IQRs], or numbers (%). SOFA, Sequential Organ Failure Assessment; APACHE, Acute 
Physiology and Chronic Health Evaluation; ICU, intensive care unit; SD, standard deviation; IQR, interquartile ranges.
defined septic shock, and categorized them as meeting 
sepsis-3 criteria of septic shock and those who met only the 
old criteria for septic shock. However they excluded patients 
who had an elevated serum lactate without SBP less than 90 
mmHg. Moreover as all patients in their parent studies did 
not have a MAP documented, only SBP less than 90 mmHg 
was used for determining hypotension in the analysis (25). 
On the other hand, Henning et al. combined three different 
cohorts and each cohort had heterogeneous inclusion 
criteria. Cohort 1 patients had to obtain blood culture, 
cohort 3 had to receive antibiotics and meanwhile cohort 
2 included by only infection related diagnosis. Since they 
wanted to know a diagnostic value of sepsis-3 definition 
among suspected infection patients, they did not purify the 
population, which differ from our study (26). 
In our present study ignoring participants who met the 
criteria for sepsis-3 shock, leaving those who met the 1991 
definition septic shock only, sepsis-induced hypoperfusion 
without hypotension (lactate >4 mmo/L and MAP 
≥70 mmHg, n=206) and refractory hypotension without 
hyperlactatemia (MAP <70 mmHg and lactate <2 mmol/L, 
n=248) were examined. Compared to the sepsis-3 shock 
group, such patients had less severe organ failure scores and 
mortality (Table 2). The in-hospital mortality of the sepsis-3 
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group vs. the 1991 group was 26.8% vs. 17.6%, P<0.001. In 
contrast to previous studies, we analyzed 28-day mortality 
as well as 90-day mortality, which were significantly higher 
in the sepsis-3 shock group (25.1% vs. 16.5%, P=0.003; 
32.1% vs. 23.3%, P=0.002).
In a previous study, the medi an SOFA score was higher 
in the sepsis-3 group than the 1991 only group (9.0 vs. 5.0, 
P<0.001) (25), and this was similar in our study (9.3 vs. 6.6, 
P<0.001). In addition, when we analyzed the APACHE-
II score, it also higher in the sepsis-3 group (20.0 vs. 15.0, 
P<0.001), which means the sepsis-3 definition of septic 
shock successfully selects patients with greater severity. 
However, the remaining patients in the 1991 group still 
had high severity scores (6.6 SOFA and 15.0 APACHE-II). 
Each score predicts 15–20% and 24% of mortality (27,28), 
and their overall 28- and 90-day mortality rates were 16.5% 
and 23.3%, respectively. Moreover, the length of stay in 
ICU and total hospital stay of the groups did not differ 
significantly (5.0 vs. 4.0, P=0.322; 13.0 vs. 12.0, P=0.088). 
In a previous multicenter study, although ICU day was 
longer in the sepsis-3 shock group (3.2 vs. 2.5, P=0.006), 
the median total hospital stay was 8.0 days for both groups 
(P=0.466) (25).
Most recent published two studies which compare 
sepsis-3 septic shock and previous septic shock definition, 
reported that there were higher ICU mortality (38.9% vs. 
34.0%; 46.7% vs. 25.6%) and in hospital mortality (47% 
vs. 43%; 55.5% vs.35.1%) in sepsis-3 septic shock, too. 
Moreover, APACHE-II scores were also higher in sepsis-3 
septic shock group (27±8 vs. 26±8; 22.0±7.1 vs. 19.2±6.8) 
(29,30). However they could not comparing analyze to 
assess the significance of the different outcomes between 
two groups, because their two groups had overlapping 
patients from a single source population. 
Limitations
This study had several limitations of note. First, it was 
an observational study, and the groups were not blinded. 
Although patients were treated protocol-driven septic shock 
management, this could have affected our results. Second, 
because it was a multicenter study, the enrollment periods 
and case volumes varied according to hospital. Third, 
because it was a prospective registry study of septic shock, 
we could not collect all infected patients as well as some 
patients were excluded from this study for their refusal to 
give informed consent. Fourth, as the KoSS registry has been 
collected by international surviving sepsis guideline (16), 
hypotension defined MAP <70 mmHg but, sepsis-3 defined 
septic shock is MBP ≤65 mmHg (8). It may overestimate 
the number of patients included in the sepsis-3 septic shock. 
And finally we focused on early septic shock patients in the 
ED, not the ICU, which might have led to selection bias. 
Conclusions
In this KoSS septic shock registry, which included 10 EDs, 
the prevalence of septic shock according to the sepsis-3 
criteria was 55.8%. The group meeting the sepsis-3 criteria 
had higher mortality and severity than the remaining group, 
Figure 2 In-hospital 28- and 90-day mortalities of each septic shock groups.
(Septic shock groups)
Sepsis-3 septic shock
1991 septic shock
Hyperlactatemia without 
hypotension
Refractory hypotension 
with normal lactate
23.3%
15.0%
19.9%
10.9%
25.1%
16.5%
21.8%
12.1%
32.1%
23.3%
29.6%
(Mortality)
In-hospital mortality 28-day mortality 90-day mortality
18.1%
0%             5%             10%           15%           20%           25%            30%           35%
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meeting only the 1991 definition of septic shock. However, 
only the 1991 group still had high mortality and severity. 
They also needed similar lengths of stay in the ICU and 
hospital management. The new definition of septic shock 
successfully selected patients with higher severities and 
worse outcomes. However, the previous definition of 
septic shock still helped to screen critical patients earlier. 
Therefore, our results could inform the choice of septic 
shock criteria for identifying patients who may die (sepsis-3) 
or who will need early screening (old definition).
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